These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 1649791)
1. Epstein-Barr virus activators, mutagens and volatile nitrosamines in preserved food samples from high-risk areas for nasopharyngeal carcinoma. Bouvier G; Poirier S; Shao YM; Malaveille C; Ohshima H; Polack A; Bornkamm GW; Zeng Y; de-Thé G; Bartsch H IARC Sci Publ; 1991; (105):204-9. PubMed ID: 1649791 [TBL] [Abstract][Full Text] [Related]
2. Volatile nitrosamine levels and genotoxicity of food samples from high-risk areas for nasopharyngeal carcinoma before and after nitrosation. Poirier S; Bouvier G; Malaveille C; Ohshima H; Shao YM; Hubert A; Zeng Y; de Thé G; Bartsch H Int J Cancer; 1989 Dec; 44(6):1088-94. PubMed ID: 2558079 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus activation in Raji cells by extracts of preserved food from high risk areas for nasopharyngeal carcinoma. Shao YM; Poirier S; Ohshima H; Malaveille C; Zeng Y; de Thé G; Bartsch H Carcinogenesis; 1988 Aug; 9(8):1455-7. PubMed ID: 2841048 [TBL] [Abstract][Full Text] [Related]
4. Occurrence of volatile nitrosamines in food samples collected in three high-risk areas for nasopharyngeal carcinoma. Poirier S; Hubert A; de-Thé G; Ohshima H; Bourgade MC; Bartsch H IARC Sci Publ; 1987; (84):415-9. PubMed ID: 3679412 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of cell immortalization mediated by EB viral activation of telomerase in nasopharyngeal carcinoma. Liu JP; Cassar L; Pinto A; Li H Cell Res; 2006 Oct; 16(10):809-17. PubMed ID: 17016469 [TBL] [Abstract][Full Text] [Related]
7. A comparison study of different PCR assays in measuring circulating plasma epstein-barr virus DNA levels in patients with nasopharyngeal carcinoma. Le QT; Jones CD; Yau TK; Shirazi HA; Wong PH; Thomas EN; Patterson BK; Lee AW; Zehnder JL Clin Cancer Res; 2005 Aug; 11(16):5700-7. PubMed ID: 16115906 [TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus early antigen induction in Raji cells by Chinese medicinal herbs. Zeng Y; Zhong JM; Mo YK; Miao XC Intervirology; 1983; 19(4):201-4. PubMed ID: 6305871 [TBL] [Abstract][Full Text] [Related]
9. Quantitative Epstein-Barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma. Tong JH; Tsang RK; Lo KW; Woo JK; Kwong J; Chan MW; Chang AR; van Hasselt CA; Huang DP; To KF Clin Cancer Res; 2002 Aug; 8(8):2612-9. PubMed ID: 12171892 [TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma. Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574 [TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of Epstein-Barr virus derived from a nasopharyngeal carcinoma that has transforming and lytic properties. Sato H; Takimoto T; Ogura H; Tanaka J; Hatano M; Glaser R J Natl Cancer Inst; 1986 Jun; 76(6):1019-24. PubMed ID: 3012175 [TBL] [Abstract][Full Text] [Related]
12. Characterization of macromolecular lignins as Epstein-Barr virus inducer in foodstuff associated with nasopharyngeal carcinoma risk. Bouvier G; Hergenhahn M; Polack A; Bornkamm GW; de Thé G; Bartsch H Carcinogenesis; 1995 Aug; 16(8):1879-85. PubMed ID: 7634418 [TBL] [Abstract][Full Text] [Related]
13. Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer. Chia MC; Leung A; Krushel T; Alajez NM; Lo KW; Busson P; Klamut HJ; Bastianutto C; Liu FF Clin Cancer Res; 2008 Feb; 14(4):984-94. PubMed ID: 18281530 [TBL] [Abstract][Full Text] [Related]
14. Differences in the ability of cells to fuse are mediated by strains of Epstein-Barr virus. Takimoto T; Sato H; Ogura H; Tanaka S; Masuda K; Ishikawa S; Umeda R Laryngoscope; 1989 Oct; 99(10 Pt 1):1075-80. PubMed ID: 2552238 [TBL] [Abstract][Full Text] [Related]
16. Independent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: a 20-year follow-up study on 9,622 males without family history in Taiwan. Hsu WL; Chen JY; Chien YC; Liu MY; You SL; Hsu MM; Yang CS; Chen CJ Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1218-26. PubMed ID: 19336547 [TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus immune response in high-risk nasopharyngeal carcinoma families in Greenland. Friborg J; Jarrett RF; Liu MY; Falk KI; Koch A; Olsen OR; Duncan P; Wohlfarht J; Chen JY; Melbye M J Med Virol; 2007 Dec; 79(12):1877-81. PubMed ID: 17935169 [TBL] [Abstract][Full Text] [Related]
18. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies. Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762 [TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of epithelial-cadherin gene promoter is associated with Epstein-Barr virus in nasopharyngeal carcinoma. Niemhom S; Kitazawa S; Kitazawa R; Maeda S; Leopairat J Cancer Detect Prev; 2008; 32(2):127-34. PubMed ID: 18632221 [TBL] [Abstract][Full Text] [Related]
20. [Biology of the Epstein-Barr virus]. Morand P; Seigneurin JM Ann Biol Clin (Paris); 1989; 47(7):421-7. PubMed ID: 2554764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]